Neuroprosthetics 2009 national conference to focus on artificial limbs

'Neuroprosthetics 2009: Today's Progress, Tomorrow's Promise' will help advance the development of the next-generation in artificial limbs that more closely replicate the function of natural limbs

On September 16, leaders in research and development of implantable limb neuroprosthetics will gather at Worcester Polytechnic Institute (WPI) to discuss the state of the field and to advance collaborations that will push next-generation artificial limbs and prosthetic devices closer to clinical application.

Organized by the Center for Neuroprosthetics in WPI's Bioengineering Institute (BEI), with grant support from the John Adams Innovation Institute, "Neuroprosthetics 2009: Today's Progress, Tomorrow's Promise" is the only national conference this year focused on the scientific and engineering problems that must be solved to enable a new generation of artificial limbs that more closely replicate the function of natural limbs.

"There is a great human need for better, more functional prosthetic devices, especially for our soldiers who have been severely injured in Iraq and Afghanistan," says W. Grant McGimpsey, professor of chemistry and biochemistry and director of the BEI, who organized the event. "We are very pleased to sponsor and host this symposium, so that many of the best minds in this field can come together, interact and discuss how to attack the very complicated problems that need to be solved if we are to realize the progress that so many people hope for and would benefit from."

More than 150 scientists, engineers, clinicians and other professionals from around the country who work in various facets of the prosthetics and neuroprosthetics fields are expected to attend.

Plenary speakers include:

  • Lt. Colonel Paul Pasquina, M.D., chief of the Integrated Department of Orthopedics and Rehabilitation and medical director of the Amputee Program, Walter Reed Army Medical Center, Washington, D.C.

  • Buddy Ratner, PhD, director of University of Washington Engineered Biomaterials and professor of bioengineering and chemical engineering at the university

  • Todd Kuiken, MD, PhD, director of the Neural Engineering Center for Artificial Limbs, Rehabilitation Institute of Chicago, Northwestern University

  • John E. Olerud, MD, George Odland Professor and head of the Division of Dermatology, University of Washington

  • Kent N. Bachus, PhD, research associate professor and director of the Harold K. Dunn Orthopaedic Research Laboratory, University of Utah

  • James Peter Beck, MD, adjunct professor, Department of Orthopaedics, Bone and Joint Research Lab, University of Utah

  • Christopher Allan, MD, associate professor, Department of Orthopaedics and Sports Medicine, Harborview Medical Center, University of Washington School of Medicine

  • George Pins, PhD, associate professor, Department of Biomedical Engineering, Worcester Polytechnic Institute

The day-long symposium will be held in WPI's Campus Center in Worcester, Mass. Registration begins at 8:30 a.m. The event is free, and the morning and afternoon plenary sessions are open to the public. Afternoon break-out sessions are by invitation only.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research explores how omega-3 and omega-6 fatty acids may impact cancer rates